Health CatalystvsNVIDIA

HCAT and NVDA stock compared: price, dividend, valuation and results, from SEC filings.

HCAT

Health Catalyst, Inc

$1.38

Value $102M

-8.61%
HCAT's page

NVDA

NVIDIA Corporation

$156.14

Value $3.79T

-4.12%
NVDA's page

Health Catalyst (HCAT) has a market value of $102M and NVIDIA (NVDA) $3.79T. Over the last year, with dividends, HCAT moved -39.2% and NVDA -17.7%. Dividend yield: HCAT none, NVDA 0.33%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    HCAT$102M

    NVDA$3.79T

    NVDA is 37,363 times HCAT

  • Revenue, 12 months

    HCAT$272M

    NVDA$303B

    NVDA is 1,113 times HCAT

  • Net income, 12 months

    HCAT-$202M

    NVDA$193B

  • Operating margin

    HCAT-65.7%

    NVDA65.2%

    130.9 points apart

  • ROIC

    HCAT-44.9%

    NVDA95.6%

    140.4 points apart

  • P/E

    HCAT–

    NVDA19.7

  • Dividend yield

    HCAT0.0%

    NVDA0.3%

    0.3 points apart

  • 5-year return

    HCAT-97.2%

    NVDA+422.4%

    519.6 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

HCAT-97.2%

NVDA+422.4%

025050075020222023202420252026
Returns by period
PeriodHCATWith dividendsNVDAWith dividends
1 year since November 14, 2025-39.2%Price -39.2%-17.7%Price -17.9%
3 years since November 16, 2023-82.4%-44.0% a yearPrice -82.4%+216.5%+46.8% a yearPrice +215.6%
5 years since November 15, 2021-97.2%-51.1% a yearPrice -97.2%+422.4%+39.2% a yearPrice +420.1%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

HCATHealth CatalystNVDANVIDIA

Valuation

HCATNVDA
Valuation
Price$1.38$156.14
Market value$102M$3.79T
Enterprise value (EV)$23M$3.77T
P/E–19.7
P/E, 5-year median–49.9
P/B0.716.6
EV/EBIT–19.1
Free cash flow yield25.3%3.4%

Results and growth

HCATNVDA
Results and growth
Revenue, 12 months$272M$303B
Net income, 12 months-$202M$193B
Free cash flow, 12 months$26M$127B
Earnings per share, 12 months-$2.85$7.91
Revenue growth, year on year1.5%65.5%
Revenue growth a year, past+10.5%over 5 years+66.9%over 5 years
EPS growth a year, past–+95.2%over 5 years

Margins and returns on capital

HCATNVDA
Margins and returns on capital
Gross margin49.1%74.7%
Operating margin-65.7%65.2%
Net margin-74.2%63.7%
ROIC-44.9%95.6%
ROE-105.0%120.4%

Balance sheet

HCATNVDA
Balance sheet
Cash$79M$56.6B
Total debt$16M$38.9B
Net debt / EBITDA–-0.1
Interest cover–426.7×

Dividends and buybacks

HCATNVDA
Dividends and buybacks
Dividend yield–0.3%
Dividend per share, 12 months–$0.52
Dividend growth a year, past–+20.1%over 5 years
Buyback yield4.9%1.1%
Shareholder yield4.9%1.4%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: HCAT or NVDA

Didn't find what you were looking for?

Ask us
Which is bigger, Health Catalyst or NVIDIA?

By market value, NVIDIA ($3.79T) is about 37,363.3 times Health Catalyst ($102M), at today's prices.

How did HCAT and NVDA stock do over the last 5 years?

Since November 15, 2021, HCAT's price moved -97.2% and NVDA's +420.1%. With dividends: HCAT -97.2% (-51.1% a year), NVDA +422.4% (+39.2% a year). Past returns do not predict future ones.

Which pays the higher dividend, HCAT or NVDA?

The dividend yield at today's price is none for Health Catalyst and 0.33% for NVIDIA. Over the last twelve months they paid – and $0.52 per share.

Which has the higher profit margins, Health Catalyst or NVIDIA?

Over the last twelve months, the net margin was -74.2% for Health Catalyst and 63.7% for NVIDIA, and the operating margin -65.7% and 65.2%. Revenue was $272M and $303B.

Which is the better investment, Health Catalyst or NVIDIA?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.